Mark Goldstein
Hematology & Oncology · van Nuys, CANPI 1487758033
Payments from drug & device makers
Across 227 payments — averaging $21.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$668
- Genentech USA, Inc.$351
- E.r. Squibb & Sons, L.L.C.$337
- Merck$240
- Sanofi$236
- Taiho Oncology, Inc.$213
- plus $3K from 34 others
What the payments were for
- Food & beverage$4,67097%
- Education$1273%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 28 | $668 |
| Genentech USA, Inc. | 20 | $351 |
| E.r. Squibb & Sons, L.L.C. | 20 | $337 |
| Merck | 13 | $240 |
| Sanofi | 13 | $236 |
| Taiho Oncology, Inc. | 4 | $213 |
| Seagen Inc. | 10 | $207 |
| Novartis | 10 | $202 |
| Bristol Myers Squibb | 8 | $186 |
| Incyte Corporation | 11 | $177 |
| Amgen | 6 | $175 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $142 |
| Puma Biotechnology, Inc. | 6 | $139 |
| Lilly USA, LLC | 7 | $135 |
| Johnson & Johnson(2 entities) | 6 | $121 |
| Rigel Pharmaceuticals, Inc. | 5 | $105 |
| Tesaro, Inc. | 4 | $103 |
| Pfizer | 7 | $100 |
| Boehringer Ingelheim | 5 | $96 |
| Teva Pharmaceuticals USA, Inc. | 5 | $91 |
| Aurobindo Pharma USA, Inc. | 1 | $87 |
| Bayer | 4 | $84 |
| EMD Serono, Inc. | 3 | $68 |
| Clovis Oncology, Inc. | 3 | $68 |
| Daiichi Sankyo Inc. | 3 | $63 |
| Mylan Institutional Inc. | 2 | $47 |
| Eisai Inc. | 2 | $46 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $46 |
| Jazz Pharmaceuticals Inc. | 2 | $44 |
| Karyopharm Therapeutics Inc. | 1 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Tersera Therapeutics LLC | 1 | $24 |
| Astellas Pharma US Inc | 1 | $24 |
| Array Biopharma Inc | 1 | $22 |
| Novocure Inc. | 1 | $22 |
| Lexicon Pharmaceuticals, Inc. | 1 | $18 |
| Exelixis Inc. | 1 | $17 |
| Secura Bio, Inc. | 1 | $17 |
| Beigene USA, Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $1 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lonsurf$155
How this compares
$4,798 in reported general payments places this provider in the 40th percentile of 1,363 hematology & oncology providers in California.
Other hematology & oncology in van Nuys
- Alain AlgaziSan Francisco$119.2M
- David BerzLos Angeles$43.3M
- Jonathan GoldmanSanta Monica$35.7M
- Omid HamidSanta Monica$23.7M
- Nicholas McAndrewLos Angeles$22.9M
- Aditya BardiaSanta Monica$22.1M
- Joseph TuscanoSacramento$20.4M
- Zev WainbergSanta Monica$19.3M
- Caitlin CostelloSan Diego$16.9M
- Rana McKaySan Diego$15.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.